Viewing Study NCT06233357

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:35 PM
Ignite Modification Date: 2026-02-20 @ 3:37 PM
Study NCT ID: NCT06233357
Status: COMPLETED
Last Update Posted: 2024-02-01
First Post: 2024-01-22
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Critically Ill ICU Patients Under Casirivimab- and/or Tocilizumab Application
Sponsor: University of Ulm
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None COVID-19 View
None Outcome, Fatal View
None Tocilizumab View
None Interleukin 6 View
None Critically Ill View
Keywords:

Keywords

Keyword Brief Keyword Text View
None COVID-19 View
None critically ill View
None ICU View
None casirivimab imdevimab View
None tocilizumab View
None interleukin 6 View
None C-reactive protein View
None ferritin View
None procalcitonin View
None mortality View